- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Current status of BAFF targeting immunotherapy in B-cell neoplasm ; volume:29 ; number:11 ; day:2 ; month:9 ; year:2024 ; pages:1676-1683 ; date:11.2024
International journal of clinical oncology ; 29, Heft 11 (2.9.2024), 1676-1683, 11.2024
- Creator
-
Tagami, Nami
Yuda, Junichiro
Goto, Yasuyuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10147-024-02611-2
- URN
-
urn:nbn:de:101:1-2501162101047.008811331534
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tagami, Nami
- Yuda, Junichiro
- Goto, Yasuyuki
- SpringerLink (Online service)
Other Objects (12)
b.a.f.f. E.V.
B-cell activating factor BAFF reflects patients immunological risk profile after kidney transplantation
BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
Schrieber-Ausstellung: "Baff"
BAFF and BAFF-receptor in B cell selection and survival
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Salivary and Serum B-cell Activating Factor (BAFF) Levels after Hydroxychloroquine Treatment in Primary Sjögren's Syndrome
TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss
b.a.f.f. E.V.
B-cell activating factor BAFF reflects patients immunological risk profile after kidney transplantation
BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
Schrieber-Ausstellung: "Baff"
BAFF and BAFF-receptor in B cell selection and survival
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Salivary and Serum B-cell Activating Factor (BAFF) Levels after Hydroxychloroquine Treatment in Primary Sjögren's Syndrome
TriBAFF-CAR-T cells eliminate B-cell malignancies with BAFFR-expression and CD19 antigen loss
b.a.f.f. E.V.
B-cell activating factor BAFF reflects patients immunological risk profile after kidney transplantation
BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy
Schrieber-Ausstellung: "Baff"
BAFF and BAFF-receptor in B cell selection and survival
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Salivary and Serum B-cell Activating Factor (BAFF) Levels after Hydroxychloroquine Treatment in Primary Sjögren's Syndrome